Is AEXAF or JNJ a better dividend investment in 2026?

AEXAF currently yields 3.23% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: JNJ offers higher current income.

What is the dividend yield difference between AEXAF and JNJ?

AEXAF has a forward dividend yield of 3.23% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 0.13 percentage points.

Home › Compare › AEXAF vs JNJ

AEXAF vs JNJ: Dividend Comparison 2026

AEXAF yields 3.23% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 AEXAF wins by $4.6K in total portfolio value

INVESTMENT

TIME HORIZON10 years

AEXAF

● Live price

3.23%

Share price

$62.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$24.6K

Annual income

$397.04

Full AEXAF calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — AEXAF vs JNJ

📍 AEXAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	AEXAF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, AEXAF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

AEXAF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AEXAF

Annual income on $10K today (after 15% tax)

$274.19/yr

After 10yr DRIP, annual income (after tax)

$337.48/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, JNJ beats the other by $366.13/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AEXAF + JNJ for your $10,000?

AEXAF: 50%JNJ: 50%

100% JNJ50/50100% AEXAF

Portfolio after 10yr

$22.3K

Annual income

$612.41/yr

Blended yield

2.74%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

AEXAF

Analyst Ratings

Hold

Consensus: Hold

Altman Z

2.6

Piotroski

4/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AEXAF buys

JNJ buys

No recent congressional trades found for AEXAF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAEXAFJNJ

Forward yield	3.23%	3.36% ✓
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$24.6K ✓	$20.0K
Annual income after 10y	$397.04	$827.78 ✓
Total dividends collected	$3.6K	$5.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Hold	Buy

Year-by-year: AEXAF vs JNJ ($10,000, DRIP)

Year	AEXAF Portfolio	AEXAF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,023	$322.58	$10,676	$355.77	+$347.00 → AEXAF
2	$12,126	$332.31	$11,407	$389.39	+$719.00 → AEXAF
3	$13,317	$341.67	$12,198	$426.53	+$1.1K → AEXAF
4	$14,600	$350.67	$13,056	$467.62	+$1.5K → AEXAF
5	$15,981	$359.30	$13,987	$513.12	+$2.0K → AEXAF
6	$17,467	$367.56	$14,998	$563.56	+$2.5K → AEXAF
7	$19,066	$375.46	$16,098	$619.52	+$3.0K → AEXAF
8	$20,783	$383.00	$17,295	$681.69	+$3.5K → AEXAF
9	$22,628	$390.19	$18,599	$750.82	+$4.0K → AEXAF
10	$24,609	$397.04	$20,022	$827.78	+$4.6K → AEXAF

AEXAF vs JNJ: Complete Analysis 2026

AEXAF — Stock

Atos SE provides digital transformation solutions and services worldwide. It offers cloud, cybersecurity, and computing solutions, as well as end-to-end vertical solutions, data platforms, and infrastructure solutions. The company's solutions include advanced computing; analytics, artificial intelligence, and automation; cloud solutions; customer journey analytics and digital customer experience; advance detection and response, data protection and governance, and trusted digital identities, as well as digital workplace, hybrid cloud, and IoT and OT security; digital consulting; digital workplace; and edge computing and Internet of things. It also offers infrastructure and foundation services. It serves energy and utilities, financial services and insurance, healthcare and life sciences, manufacturing, public sector and defense, telecommunications and media, transport and logistics, and retail industries. Atos SE was incorporated in 1982 and is headquartered in Bezons, France.

Full AEXAF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this AEXAF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AEXAF vs SCHD AEXAF vs JEPI AEXAF vs O AEXAF vs KO AEXAF vs MAIN AEXAF vs ABBV AEXAF vs MRK AEXAF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.